Cargando…

Proteomic and metabolomic changes driven by elevating myocardial creatine suggest novel metabolic feedback mechanisms

Mice over-expressing the creatine transporter have elevated myocardial creatine levels [Cr] and are protected against ischaemia/reperfusion injury via improved energy reserve. However, mice with very high [Cr] develop cardiac hypertrophy and dysfunction. To investigate these contrasting effects, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Zervou, Sevasti, Yin, Xiaoke, Nabeebaccus, Adam A., O’Brien, Brett A., Cross, Rebecca L., McAndrew, Debra J., Atkinson, R. Andrew, Eykyn, Thomas R., Mayr, Manuel, Neubauer, Stefan, Lygate, Craig A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974297/
https://www.ncbi.nlm.nih.gov/pubmed/27143170
http://dx.doi.org/10.1007/s00726-016-2236-x
_version_ 1782446528068059136
author Zervou, Sevasti
Yin, Xiaoke
Nabeebaccus, Adam A.
O’Brien, Brett A.
Cross, Rebecca L.
McAndrew, Debra J.
Atkinson, R. Andrew
Eykyn, Thomas R.
Mayr, Manuel
Neubauer, Stefan
Lygate, Craig A.
author_facet Zervou, Sevasti
Yin, Xiaoke
Nabeebaccus, Adam A.
O’Brien, Brett A.
Cross, Rebecca L.
McAndrew, Debra J.
Atkinson, R. Andrew
Eykyn, Thomas R.
Mayr, Manuel
Neubauer, Stefan
Lygate, Craig A.
author_sort Zervou, Sevasti
collection PubMed
description Mice over-expressing the creatine transporter have elevated myocardial creatine levels [Cr] and are protected against ischaemia/reperfusion injury via improved energy reserve. However, mice with very high [Cr] develop cardiac hypertrophy and dysfunction. To investigate these contrasting effects, we applied a non-biased hypothesis-generating approach to quantify global protein and metabolite changes in the LV of mice stratified for [Cr] levels: wildtype, moderately elevated, and high [Cr] (65–85; 100–135; 160–250 nmol/mg protein, respectively). Male mice received an echocardiogram at 7 weeks of age with tissue harvested at 8 weeks. RV was used for [Cr] quantification by HPLC to select LV tissue for subsequent analysis. Two-dimensional difference in-gel electrophoresis identified differentially expressed proteins, which were manually picked and trypsin digested for nano-LC–MS/MS. Principal component analysis (PCA) showed efficient group separation (ANOVA P ≤ 0.05) and peptide sequences were identified by mouse database (UniProt 201203) using Mascot. A total of 27 unique proteins were found to be differentially expressed between normal and high [Cr], with proteins showing [Cr]-dependent differential expression, chosen for confirmation, e.g. α-crystallin B, a heat shock protein implicated in cardio-protection and myozenin-2, which could contribute to the hypertrophic phenotype. Nuclear magnetic resonance (¹H-NMR at 700 MHz) identified multiple strong correlations between [Cr] and key cardiac metabolites. For example, positive correlations with α-glucose (r² = 0.45; P = 0.002), acetyl-carnitine (r² = 0.50; P = 0.001), glutamine (r² = 0.59; P = 0.0002); and negative correlations with taurine (r² = 0.74; P < 0.0001), fumarate (r² = 0.45; P = 0.003), aspartate (r² = 0.59; P = 0.0002), alanine (r² = 0.66; P < 0.0001) and phosphocholine (r² = 0.60; P = 0.0002). These findings suggest wide-ranging and hitherto unexpected adaptations in substrate utilisation and energy metabolism with a general pattern of impaired energy generating pathways in mice with very high creatine levels. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00726-016-2236-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4974297
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-49742972016-08-17 Proteomic and metabolomic changes driven by elevating myocardial creatine suggest novel metabolic feedback mechanisms Zervou, Sevasti Yin, Xiaoke Nabeebaccus, Adam A. O’Brien, Brett A. Cross, Rebecca L. McAndrew, Debra J. Atkinson, R. Andrew Eykyn, Thomas R. Mayr, Manuel Neubauer, Stefan Lygate, Craig A. Amino Acids Original Article Mice over-expressing the creatine transporter have elevated myocardial creatine levels [Cr] and are protected against ischaemia/reperfusion injury via improved energy reserve. However, mice with very high [Cr] develop cardiac hypertrophy and dysfunction. To investigate these contrasting effects, we applied a non-biased hypothesis-generating approach to quantify global protein and metabolite changes in the LV of mice stratified for [Cr] levels: wildtype, moderately elevated, and high [Cr] (65–85; 100–135; 160–250 nmol/mg protein, respectively). Male mice received an echocardiogram at 7 weeks of age with tissue harvested at 8 weeks. RV was used for [Cr] quantification by HPLC to select LV tissue for subsequent analysis. Two-dimensional difference in-gel electrophoresis identified differentially expressed proteins, which were manually picked and trypsin digested for nano-LC–MS/MS. Principal component analysis (PCA) showed efficient group separation (ANOVA P ≤ 0.05) and peptide sequences were identified by mouse database (UniProt 201203) using Mascot. A total of 27 unique proteins were found to be differentially expressed between normal and high [Cr], with proteins showing [Cr]-dependent differential expression, chosen for confirmation, e.g. α-crystallin B, a heat shock protein implicated in cardio-protection and myozenin-2, which could contribute to the hypertrophic phenotype. Nuclear magnetic resonance (¹H-NMR at 700 MHz) identified multiple strong correlations between [Cr] and key cardiac metabolites. For example, positive correlations with α-glucose (r² = 0.45; P = 0.002), acetyl-carnitine (r² = 0.50; P = 0.001), glutamine (r² = 0.59; P = 0.0002); and negative correlations with taurine (r² = 0.74; P < 0.0001), fumarate (r² = 0.45; P = 0.003), aspartate (r² = 0.59; P = 0.0002), alanine (r² = 0.66; P < 0.0001) and phosphocholine (r² = 0.60; P = 0.0002). These findings suggest wide-ranging and hitherto unexpected adaptations in substrate utilisation and energy metabolism with a general pattern of impaired energy generating pathways in mice with very high creatine levels. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00726-016-2236-x) contains supplementary material, which is available to authorized users. Springer Vienna 2016-05-03 2016 /pmc/articles/PMC4974297/ /pubmed/27143170 http://dx.doi.org/10.1007/s00726-016-2236-x Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Zervou, Sevasti
Yin, Xiaoke
Nabeebaccus, Adam A.
O’Brien, Brett A.
Cross, Rebecca L.
McAndrew, Debra J.
Atkinson, R. Andrew
Eykyn, Thomas R.
Mayr, Manuel
Neubauer, Stefan
Lygate, Craig A.
Proteomic and metabolomic changes driven by elevating myocardial creatine suggest novel metabolic feedback mechanisms
title Proteomic and metabolomic changes driven by elevating myocardial creatine suggest novel metabolic feedback mechanisms
title_full Proteomic and metabolomic changes driven by elevating myocardial creatine suggest novel metabolic feedback mechanisms
title_fullStr Proteomic and metabolomic changes driven by elevating myocardial creatine suggest novel metabolic feedback mechanisms
title_full_unstemmed Proteomic and metabolomic changes driven by elevating myocardial creatine suggest novel metabolic feedback mechanisms
title_short Proteomic and metabolomic changes driven by elevating myocardial creatine suggest novel metabolic feedback mechanisms
title_sort proteomic and metabolomic changes driven by elevating myocardial creatine suggest novel metabolic feedback mechanisms
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974297/
https://www.ncbi.nlm.nih.gov/pubmed/27143170
http://dx.doi.org/10.1007/s00726-016-2236-x
work_keys_str_mv AT zervousevasti proteomicandmetabolomicchangesdrivenbyelevatingmyocardialcreatinesuggestnovelmetabolicfeedbackmechanisms
AT yinxiaoke proteomicandmetabolomicchangesdrivenbyelevatingmyocardialcreatinesuggestnovelmetabolicfeedbackmechanisms
AT nabeebaccusadama proteomicandmetabolomicchangesdrivenbyelevatingmyocardialcreatinesuggestnovelmetabolicfeedbackmechanisms
AT obrienbretta proteomicandmetabolomicchangesdrivenbyelevatingmyocardialcreatinesuggestnovelmetabolicfeedbackmechanisms
AT crossrebeccal proteomicandmetabolomicchangesdrivenbyelevatingmyocardialcreatinesuggestnovelmetabolicfeedbackmechanisms
AT mcandrewdebraj proteomicandmetabolomicchangesdrivenbyelevatingmyocardialcreatinesuggestnovelmetabolicfeedbackmechanisms
AT atkinsonrandrew proteomicandmetabolomicchangesdrivenbyelevatingmyocardialcreatinesuggestnovelmetabolicfeedbackmechanisms
AT eykynthomasr proteomicandmetabolomicchangesdrivenbyelevatingmyocardialcreatinesuggestnovelmetabolicfeedbackmechanisms
AT mayrmanuel proteomicandmetabolomicchangesdrivenbyelevatingmyocardialcreatinesuggestnovelmetabolicfeedbackmechanisms
AT neubauerstefan proteomicandmetabolomicchangesdrivenbyelevatingmyocardialcreatinesuggestnovelmetabolicfeedbackmechanisms
AT lygatecraiga proteomicandmetabolomicchangesdrivenbyelevatingmyocardialcreatinesuggestnovelmetabolicfeedbackmechanisms